Kishore Sunkara
Child & Adolescent Psychiatry · Hurst, TXNPI 1801841762
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$994
- Corium, LLC$901
- Validus Pharmaceuticals LLC$871
- Neuronetics, Inc.$707
- Supernus Pharmaceuticals, Inc.$584
- Johnson & Johnson$571
- plus $3K from 22 others
What the payments were for
- Travel & lodging$7079%
- Food & beverage$6,99091%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 54 | $994 |
| Corium, LLC | 50 | $901 |
| Validus Pharmaceuticals LLC | 11 | $871 |
| Neuronetics, Inc. | 1 | $707 |
| Supernus Pharmaceuticals, Inc. | 71 | $584 |
| Johnson & Johnson | 26 | $571 |
| Tris Pharma Inc | 23 | $447 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $440 |
| Ironshore Pharmaceuticals Inc. | 15 | $321 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $285 |
| Otsuka America Pharmaceutical, Inc. | 16 | $276 |
| Bausch Health US, LLC | 13 | $232 |
| Sunovion Pharmaceuticals Inc. | 15 | $217 |
| Axsome Therapeutics, Inc. | 6 | $129 |
| Noven Therapeutics, LLC | 5 | $112 |
| Lundbeck LLC | 6 | $108 |
| Collegium Pharmaceutical, Inc. | 5 | $85 |
| Vertical Pharmaceuticals, LLC | 4 | $76 |
| Novo Nordisk | 2 | $59 |
| Brainsway USA Inc | 1 | $57 |
| Adlon Therapeutics L.p. | 4 | $55 |
| Eisai Inc. | 3 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Merck | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Neos Therapeutics, LP | 1 | $22 |
| Biogen | 1 | $21 |
| Avion Pharmaceuticals | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY$707
- Equetro$641
- Azstarys$112
How this compares
$7,704 in reported general payments places this provider in the 95th percentile of 301 child & adolescent psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 25 | $1,014 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 18 | $679 |
| Trazodone Hcl | 24 | $151 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $143 |
| Clonazepam | 12 | $140 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Hurst
- Alain KaticBellaire$106K
- Steven PliszkaSan Antonio$59K
- Mary Garcia HolguinSan Antonio$24K
- John SteffekSpring$14K
- Robert MosquedaEdinburg$13K
- Gloria BrunGreenville$10K
- Mudassar TariqSugar Land$9K
- Charles PryzantDallas$9K
- Mehvesh AfrinaPlano$8K
- Moses RamosDesoto$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.